Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Langenbeck'S Archives of Surgery|January 10, 2023
Adrenocortical carcinoma with venous tumor invasion: is there a role for mini-invasive surgery?Alberto Olivero, Kan Liu, Enrico Checchucci, et al.
Theranostics|September 15, 2020
Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsyLizhi Shao, Ye Yan, Zhenyu Liu, et al.
Molecular Biomedicine|March 6, 2026
Interaction between transient receptor potential vanilloid 4 and glutamate NMDA receptor subunit 1 mediates endoplasmic reticulum stress and neuroinflammation in postoperative deliriumShiqian Huang, Tianhao Zhang, Yu Wang, et al.
Gigascience|May 6, 2017
Draft genome sequence of the Tibetan medicinal herb Rhodiola crenulataYuanyuan Fu, Liangwei Li, Shijie Hao, et al.
Cancer Science|October 13, 2020
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinomaDingwei Ye, Jiyan Liu, Aiping Zhou, et al.
Cancer Medicine|July 7, 2020
The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patientsZhuo Liu, Li Zhang, Peng Hong, et al.
Biomed Research International|October 21, 2020
A Predictive Model for Tumor Invasion of the Inferior Vena Cava Wall Using Multimodal Imaging in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor ThrombusZhuo Liu, Liwei Li, Peng Hong, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 12, 2024
Robot-assisted radical nephroureterectomy using the KangDuo Surgical Robot-01 System versus the da Vinci System: a multicenter prospective randomized controlled trialZhongyuan Zhang, Zhenyu Li, Weifeng Xu, et al.
Urology|March 19, 2019
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled TrialZhangqun Ye, Jian Huang, Liqun Zhou, et al.
Asian Journal of Urology|December 22, 2017
Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0-10.0 ng/mL: Results from the Chinese Prostate Cancer ConsortiumRui Chen, Liping Xie, Xiaobing Cai, et al.
Pageof 22